MYO
Myomo, Inc. AMEX Listed Jun 12, 2017$1.25
-2.34%
vs $1.28
Mkt Cap $52.3M
52w Low $0.64
34.3% of range
52w High $2.42
50d MA $0.99
200d MA $0.91
P/E (TTM)
-3.5x
EV/EBITDA
—
P/B
4.6x
Debt/Equity
1.7x
ROE
-136.6%
P/FCF
-3.2x
RSI (14)
52.70
ATR (14)
$0.20
Beta
1.16
50d MA
$0.99
200d MA
$0.91
Avg Volume
1.0M
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
45 Blue Sky Dr. · Burlington, MA 01803 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.12 | -0.09 | +25.0% | 0.87 | +2.1% | -5.0% | +2.7% | -8.4% | +4.5% | +9.2% | — |
| Mar 9, 2026 | AMC | -0.09 | -0.08 | +11.1% | 0.81 | -7.6% | -16.8% | +5.9% | -3.7% | +1.2% | +6.2% | — |
| Nov 10, 2025 | AMC | -0.11 | -0.09 | +18.2% | 0.92 | +3.6% | -7.3% | +0.0% | -4.9% | +0.9% | -5.6% | — |
| Aug 11, 2025 | AMC | -0.11 | -0.11 | +0.0% | 1.76 | -39.8% | -38.6% | -2.8% | -6.7% | -0.5% | +14.9% | — |
| May 7, 2025 | AMC | -0.08 | -0.08 | +0.0% | 4.84 | -14.0% | -30.6% | -4.8% | +3.7% | -3.9% | +1.9% | — |
| Mar 10, 2025 | AMC | -0.02 | -0.01 | +50.0% | 4.17 | +33.6% | +40.8% | -7.5% | -6.6% | +2.4% | +4.8% | — |
| Nov 6, 2024 | AMC | -0.02 | -0.03 | -28.7% | 4.18 | +2.9% | +20.1% | -4.2% | +1.9% | +1.8% | -5.4% | — |
| Aug 6, 2024 | AMC | -0.07 | -0.03 | +57.1% | 4.20 | -5.5% | -13.3% | +5.8% | +4.4% | -4.0% | -0.8% | — |
| May 8, 2024 | AMC | -0.09 | -0.10 | -11.1% | 3.93 | -1.0% | -9.4% | +7.6% | -5.0% | -1.6% | +5.6% | — |
| Mar 7, 2024 | AMC | -0.05 | -0.07 | -40.0% | 3.52 | +0.6% | -9.4% | +14.4% | +4.1% | -3.9% | -5.8% | — |
| Nov 7, 2023 | AMC | -0.08 | -0.06 | +25.0% | 1.76 | +0.0% | +7.4% | +0.5% | +12.1% | +3.8% | +16.3% | — |
| Aug 9, 2023 | AMC | -0.03 | -0.04 | -23.1% | 0.69 | +7.0% | -7.7% | -5.8% | +16.4% | -5.7% | -16.2% | — |
| May 10, 2023 | AMC | -0.15 | -0.11 | +26.7% | 0.51 | -1.4% | -2.0% | -0.5% | -1.5% | +0.3% | -4.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 | Ascendiant Capital | Maintains | Buy → Buy | — | $0.72 | $0.72 | +0.0% | +6.4% | +9.7% | -0.2% | +3.0% | +3.1% |
| Sep 22 | Ascendiant Capital | Maintains | Buy → Buy | — | $0.87 | $0.87 | +0.0% | -2.3% | +11.6% | +9.6% | -12.5% | +2.3% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.76 | $1.06 | -39.8% | -38.6% | -2.8% | -6.7% | -0.5% | +14.9% |
| Jun 23 | Craig-Hallum | Maintains | Buy → Buy | — | $2.42 | $2.42 | +0.0% | -6.2% | +4.0% | -2.5% | -3.5% | +1.8% |
| Jun 5 | Ascendiant Capital | Maintains | Buy → Buy | — | $2.88 | $2.90 | +0.7% | +3.8% | -0.3% | -0.3% | -3.0% | -0.7% |
| May 8 | Craig-Hallum | Maintains | Buy → Buy | — | $4.84 | $4.16 | -14.0% | -30.6% | -4.8% | +3.7% | -3.9% | +1.9% |
| Mar 17 | Ascendiant Capital | Maintains | Buy → Buy | — | $5.19 | $5.22 | +0.6% | +4.8% | -2.4% | +3.2% | -1.1% | -0.7% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.87 | $6.05 | +3.1% | -7.5% | -6.6% | +2.4% | +4.8% | -2.4% |
| Mar 11 | Craig-Hallum | Maintains | Buy → Buy | — | $4.17 | $5.57 | +33.6% | +40.8% | -7.5% | -6.6% | +2.4% | +4.8% |
| Dec 13 | Craig-Hallum | Maintains | Buy → Buy | — | $6.36 | $6.31 | -0.8% | -1.6% | -3.2% | -1.0% | -6.2% | +8.2% |
| Nov 12 | Ascendiant Capital | Maintains | Buy → Buy | — | $4.90 | $4.88 | -0.4% | +1.8% | -5.4% | +2.8% | -3.9% | +1.7% |
| Aug 19 | Ascendiant Capital | Maintains | Buy → Buy | — | $3.71 | $3.71 | +0.0% | +0.3% | +1.6% | +7.1% | -4.7% | +1.0% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.02 | $4.06 | +1.0% | -4.0% | -0.8% | +0.0% | -2.1% | -1.1% |
| Jul 9 | Lake Street | Maintains | Buy → Buy | — | $4.07 | $4.08 | +0.2% | +14.3% | +7.5% | -2.2% | -6.1% | +8.9% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.93 | $3.89 | -1.0% | -9.4% | +7.6% | -5.0% | -1.6% | +5.6% |
| May 25 | Maxim Group | Maintains | Buy → Buy | — | $0.46 | $0.47 | +3.0% | +12.1% | +4.8% | +0.3% | +3.1% | -0.5% |
| Sep 16 | Colliers Securities | Maintains | Buy → Buy | — | $3.82 | $5.11 | +33.8% | +30.6% | +7.2% | -6.7% | -11.4% | +2.0% |
| Nov 14 | Roth Capital | Downgrade | Buy → Neutral | — | $16.12 | $15.60 | -3.2% | +0.5% | -5.8% | +4.2% | -0.3% | -2.7% |
| Jul 31 | Ascendiant Capital | Maintains | Buy → Buy | — | $23.70 | $23.70 | +0.0% | +6.3% | -0.7% | +0.5% | -2.2% | -1.2% |
| Mar 9 | Roth Capital | Maintains | Buy → Buy | — | $124.50 | $135.00 | +8.4% | +1.2% | +0.5% | -4.0% | -2.7% | +3.0% |
| Oct 2 | H.C. Wainwright | Maintains | Buy → Buy | — | $180.00 | $183.60 | +2.0% | -3.8% | +0.5% | -2.6% | -3.2% | +2.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | KIRK THOMAS F | — | Buy | 40,002 | $1.27 | $51K | 693,865 | +17.56% | +8.15% |
| May 28, 2026 | KIRK THOMAS F | — | Buy | 25,000 | $0.99 | $25K | 653,863 | -8.62% | +0.00% |
| May 28, 2026 | Kovelman Harry | Chief Medical Officer | Sell | 11,536 | $1.02 | $12K | 108,618 | +0.00% | +17.27% |
| May 27, 2026 | Kovelman Harry | Chief Medical Officer | Sell | 20,464 | $1.00 | $21K | 120,154 | +0.00% | +17.27% |
| May 18, 2026 | KIRK THOMAS F | — | Buy | 43,401 | $0.91 | $39K | 628,863 | +4.67% | -0.96% |
| May 15, 2026 | Manko Joseph M. Jr.Dir | — | Buy | 30,367 | $0.89 | $27K | 2,309,775 | +4.67% | -0.96% |
| May 15, 2026 | KIRK THOMAS F | — | Buy | 31,605 | $0.91 | $29K | 585,462 | +4.67% | -0.96% |
| May 14, 2026 | Mitchell Micah | Chief Commercial Officer | Sell | 90,231 | $0.86 | $78K | 109,478 | +2.34% | +22.17% |
| May 14, 2026 | Manko Joseph M. Jr.Dir | — | Buy | 170,830 | $0.86 | $147K | 2,279,408 | +4.67% | -0.96% |
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of an executive effective April 14, 2026 creates near-term leadership uncertainty and potential strategy disruption, which could pressure these small-cap stocks until succession clarity emerges.
Apr 16
8-K
Myomo Inc. -- 8-K Filing
Myomo reported $40.9M in 2025 revenue with strong recurring revenue growth and projects 2026 revenue between $43M-$46M, signaling continued market traction for its orthotic devices.
Mar 9
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | 3,847,272 | $3M | — | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 1,144,324 | $774K | New | Mar 2026 |
| 3 | Morgan Stanley | 716,908 | $652K | Added | Dec 2025 |
| 4 | Clearstead Advisors, Llc | 425,600 | $288K | — | Mar 2026 |
| 5 | Nuveen, Llc | 370,325 | $250K | — | Mar 2026 |
| 6 | Aqr Capital Management Llc | 318,951 | $215K | Reduced | Mar 2026 |
| 7 | Ubs Group Ag | 311,721 | $211K | Reduced | Mar 2026 |
| 8 | Prescott Group Capital Management, L.l.c. | 185,433 | $169K | New | Dec 2025 |
| 9 | Northern Trust Corp | 214,047 | $145K | Added | Mar 2026 |
| 10 | Vanguard Portfolio Management Llc | 205,620 | $139K | New | Mar 2026 |
| 11 | Sei Investments Co | 147,784 | $100K | — | Mar 2026 |
| 12 | Corsair Capital Management, L.p. | 100,000 | $89K | New | Sep 2025 |
| 13 | Jane Street Group, Llc | 70,620 | $64K | New | Dec 2025 |
| 14 | Bank Of New York Mellon Corp | 70,549 | $48K | — | Mar 2026 |
| 15 | Stratos Wealth Partners, Ltd. | 60,000 | $41K | — | Mar 2026 |
| 16 | Fmr Llc | 41,618 | $28K | Reduced | Mar 2026 |
| 17 | Susquehanna International Group, Llp | 38,389 | $26K | Reduced | Mar 2026 |
| 18 | Accel Wealth Management | 34,200 | $23K | Reduced | Mar 2026 |
| 19 | Ieq Capital, Llc | 33,839 | $23K | Added | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 30,101 | $20K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$52.3M
Enterprise Value
$45.1M
P/E (TTM)
-3.47x
Forward P/E
—
PEG Ratio
-0.02x
P/B
4.59x
P/S
1.27x
P/FCF
-3.22x
EV/EBITDA
—
Shares Out
41.9M
Financials (TTM)
Revenue
$41.2M
Net Income
-$15.1M
EBITDA
-$12.0M
Free Cash Flow
-$16.3M
Op Cash Flow
-$14.5M
EPS Basic
$-0.37
EPS Diluted
$-0.36
EPS Forward
$-0.34
Gross Margin
66.0%
Op Margin
-34.1%
Net Margin
-36.7%
Balance Sheet
Total Assets
$38.6M
Total Liab.
$27.2M
Total Equity
$11.4M
Cash
$18.4M
LT Debt
$11.2M
Book Value/Sh
$0.27
Debt/Equity
1.70x
Current Ratio
3.30
Quick Ratio
2.93
Returns & Growth
ROE
-136.6%
ROA
-40.3%
ROIC
-46.8%
Rev Growth YoY
+25.7%
EPS Growth YoY
-131.2%
Price Returns
2W
+22.7%
1M
+26.8%
3M
+40.6%
6M
+22.5%
12M
-63.3%
Technicals
52W High
$2.42
52W Low
$0.64
50d MA
$0.99
200d MA
$0.91
RSI (14)
52.70
ATR (14)
$0.20
Beta
1.16
Avg Volume
1.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$1.10
High
$1.10
Low
$1.10
Median
$1.10
Data updated apr 26, 2026 2:03pm
· Source: financialmodelingprep.com